Challenging the neuronal MIBG uptake by pharmacological intervention: Effect of a single dose of oral amitriptyline on regional cardiac MIBG uptake

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 31, Issue 12, 2004, Pages 1575-1580

  Estorch, Montserrat ^a   Carrió, Ignasi ^a   Mena, Esther ^a   Flotats, Albert ^a   Camacho, Valle ^a   Fuertes, Jordi ^a   Kulisewsky, Jaume ^a   Narula, Jagat ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Amitriptyline challenge; Cardiac neurotransmission; Metaiodobenzylguanidine; Pharmacological intervention; Regional MIBG distribution

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; AMITRIPTYLINE;

ADULT; AGED; ARTICLE; DRUG RETENTION; DRUG UPTAKE; FEMALE; HEART; HUMAN; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STATISTICAL SIGNIFICANCE;

3-IODOBENZYLGUANIDINE; ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; AMITRIPTYLINE; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ARTIFACTS; FEMALE; HEART; HEART CONDUCTION SYSTEM; HUMANS; MALE; MIDDLE AGED; MYOCARDIUM; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TISSUE DISTRIBUTION;

EID: 12144252363     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-004-1520-2     Document Type: Article

References (30)

1. Dae MW, O'Connell J, Botvinick EH, et al. Scintigraphic assessment of regional cardiac innervation. Circulation 1989; 79:634-644.
2. Sisson JC, Wieland DM, Sherman P, Mangner MC, Tobes MC, Jacques S. Metaiodobenzylguanidine as an index of adrenergic nervous system integrity and function. J Nucl Med 1987; 28:1620-1624.
3. Sisson JC, Bolgos G, Jhonson J. Measuring acute changes in adrenergic nerve activity of the heart in the living animal. Am Heart J 1991; 121:1119-1123.
4. 123I)iodobenzylguanidine for myocardial scintigraphy. Eur J Nucl Med 2000; 3:302-307.
5. Merlet P, Valette H, Dubois-Rande JL, et al. Prognostic value of cardiac metaiodobenzylguanidine imaging in patients with heart failure. J Nucl Med 1992; 33:471-477.
6. Merlet P, Benvenuti C, Moyse D, et al. Prognostic value of MIBG imaging in idiopathic dilated cardiomyopathy. J Nucl Med 1999; 40:917-923.
7. Maunoury C, Agostini D, Acar P, et al. Impairment of cardiac neuronal function in childhood dilated cardiomyopathy: an I123-MIBG scintigraphic study. J Nucl Med 2000; 41: 400-404.
8. Udelson J, Shafer C, Carrió I. Radionuclide imaging in heart failure: assessing etiology and outcomes and implications for management. J Nucl Cardiol 2002; 5:S40-S52.
9. Carrio I. Cardiac neurotransmission imaging. J Nucl Med 2001; 42:1062-1076.
10. Taki J, Nakajima K, Hwang EH, et al. Peripheral sympathetic dysfunction in patients with Parkinson's disease without autonomic failure is heart selective and disease specific. Eur J Nucl Med 2000; 27:566-573.
11. Takatsu H, Nishida H, Matsuo H, et al. Cardiac sympathetic denervation from the early stage of Parkinson's disease: clinical and experimental studies with radiolabeled MIBG. J Nucl Med 2000; 41:71-77.
12. Yoshita M. Differentiation of idiopathic Parkinson's disease from striatonogral degeneration and progressive supranuclear palsy using iodine-123 meta-iodobenzylguanidine myocardial scintigraphy. J Neurol Sci 1998; 155:60-67.
13. American Society of Nuclear Cardiology. Imaging guidelines for nuclear cardiology procedures, Part 2. J Nucl Cardiol 1999; 6:G47-G84.
14. Charney DS, Menkes DB, Heninger GR. Receptor sensitivity and the mechanism of action of antidepressant treatment. Arch Gen Psychiatry 1981; 38:1160-1180.
15. Stahl SM, Grady MM. Differences in mechanism of action between current and future antidepressants. J Clin Psychiatry 2003; 64 Suppl 13:13-17.
16. Malizia AL, Melichar JK, Rhodes CG, Haida A, Reynolds AH, Jones T, Nutt DJ. Desipramine binding to noradrenaline reuptake sites in cardiac sympathetic neurons in man in vivo. Eur J Pharmacol 2000; 391:263-267.
17. AHFS (American Hospital Formulary Service). Drug information (1990): antidepressants. In: McEvoy G, ed. AHFS drug information. Bethesda, MD: American Society of Hospital Pharmacists; 1990:1160-1161.
18. Hollister LE. Tricyclic antidepressants. N Engl J Med 1978; 23:1168-1172.
19. Preskorn SH, Irwin HA. Toxicity of tricyclic antidepressants: kinetics, mechanism, intervention. J Clin Psychiatry 1982; 43:151-156.
20. Stahl SM, Grady MM. Differences in mechanism of action between current and future antidepressants. J Clin Psychiatry 2003; 64 Suppl 13:13-17.
21. Huangfu D, Goodwin WB, Guyenet PG. Sympatholytic effect of tricyclic antidepressants: site and mechanism of action in anesthetized rats. Am J Physiol 1995; 268:R1429-R1441.
22. Buckley NA, Chevalier S, Leditschke IA, et al. The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose. Crit Care 2003; 5:349-350.
23. Perry PJ, Zeilmann C, Arndt S. Tricyclic antidepressant concentrations in plasma: an estimate of their sensitivity and specificity as a predictor of response. J Clin Psychopharmacol 1994; 14:230-240.
24. Tsuchimochi S, Tamaki N, Tadamura E, et al. Age and gender differences in normal myocardial adrenergic neuronal function evaluated by iodine-123-MIBG imaging. J Nucl Med 1995; 6:969-974.
25. Estorch M, Carrió I, Berná LI, Lopez J, Torres G. Myocardial iodine-labeled metaiodobenzylguanidine uptake relates to age. J Nucl Cardiol 1995; 2:126-132.
26. Gill JS, Hunter GJ, Gane G, Gamm AJ. Heterogeneity of the human myocardial sympathetic innervation: in vivo demonstration by iodine 123-labeled meta-iodobenzylguanidine scintigraphy. Am Heart J 1993; 2:390-398.
27. Kiyono Y, Iida Y, Kawashima H, et al. Norepinephrine transporter density as a causative factor in alterations in MIBG myocardial uptake in NIDDM model rats. Eur J Nucl Med Mol Imaging 2002; 8:888-1005.
28. 123I-metaiodobenzylguanidine. J Nucl Cardiol 2002; 9:608-615.
29. Toyama T, Hoshizaki H, Seki R, et al. Efficacy of carvedilol treatment on cardiac function and cardiac sympathetic nerve activity in patients with dilated cardiomyopathy: comparison with metoprolol activity. J Nucl Med 2003; 44: 1604-1611.
30. Yamazaki J, Muto H, Kabano T, Yamashina S, Nanjo S, Inoue A. Evaluation of beta-blocker therapy in patients with dilated cardiomyopathy - clinical meaning of iodine 123-metaiodobenzylguanidine myocardial single-photon emission computed tomography. Am Heart J 2001; 141:645-652.